Their approach isn’t about cloning but rewriting DNA to create a mammoth hybrid—a mix of the modern Asian elephant and woolly mammoth traits. Think of it as bringing back the mammoth’s ...

Colossal is a firm focused on bioscience and the de-extinction of species like the woolly mammoth and dodo bird.

Ben Lamm’s start-up, Colossal Biosciences, has billed itself as the world’s first ‘de-extinction’ company - Colossal Science ...

The woolly mammoth, a giant that roamed the icy expanses of the planet during the Pleistocene epoch, became extinct around 4,000 years ago and is at the center of Colossal’s mission. It’s a ...

Could we walk among the woolly mammoth once again ... a biotech company who wants to make seeing the Tasmanian tiger in real life a reality, announced it raised $200 million in investment ...

Colossal will end up creating more of a “hairy elephant” than a true woolly mammoth. Lamm says the company has never claimed its creatures would be an “identical copy” of prehistoric life.

No, this isn’t a new Jurassic Park plot: A real-life woolly mammoth could be on Earth by the decade’s end. Biotechnology start-up Colossal Biosciences Inc., which is using DNA and genomics in ...

(Bloomberg) -- A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.

including the dodo and the woolly mammoth. Other scientists are skeptical that such feats are really possible, or even advisable for conservation. | Matt Dunham ...